Sequenom Inc. Restarts Down Syndrome Test; Raises $51.6 Million Alleviating Funding Fears

Reuters -- Sequenom Inc said it has raised about $51.6 million through a private placement, alleviating investor concerns about the genetic analysis products maker’s ability to raise much-needed funding.

MORE ON THIS TOPIC